Clusters of sensory neuron cell bodies located along the dorsal (posterior) roots of spinal nerves, just outside the spinal cord. The DRG house the primary afferent neurons (pseudo-unipolar neurons) that transmit all sensory information—pain, temperature, touch, proprioception—from the periphery to the central nervous system. These ganglia are critical vulnerability points where diet-induced inflammatory signals, particularly oxylipins from omega-6 fatty acids, accumulate and sensitize pain pathways, driving peripheral neuropathy and chronic pain.
Think of the DRG as border control stations on a highway connecting the countryside (peripheral tissues) to the capital city (spinal cord/brain). Every sensory message—from a splinter in your finger to hunger signals from your gut—passes through one of these checkpoints. The neuron cell bodies sit in these stations, processing and forwarding information.
Now imagine someone starts dumping industrial waste (pro-inflammatory oxylipins from high linoleic acid diets) around these checkpoints. The border guards (DRG neurons) become hypersensitive and irritable—they start overreacting to normal traffic, flagging everything as an emergency. A light touch becomes pain; normal metabolic signals become neuropathic noise. The checkpoints themselves swell with inflammatory debris (lysophospholipids, oxidized lipids), reducing their efficiency and eventually killing off some of the staff (reduced intraepidermal nerve fibre density).
The damage isn't random—it's diet-driven. High omega-6 oils flood the system with pronociceptive waste products that specifically target the heat-sensing smoke detectors (TRPV1 channels) in these stations, making them fire at lower and lower thresholds. The highway gets noisier, the capital receives constant false alarms, and the countryside loses its ability to communicate clearly.
The DRG contains pseudo-unipolar sensory neurons with one long axon that bifurcates: one branch extends to peripheral tissues (skin, muscle, viscera), the other projects centrally to the dorsal horn of the spinal cord. These neurons express a dense array of receptors for inflammatory mediators, making them direct sensors of the metabolic and immune environment.
The Dietary Lipid Cascade:
-
Dietary LA → Oxylipin Production: High dietary linoleic acid (LA, omega-6) is metabolized by 12-LOX, 15-LOX, and COX-2 into bioactive oxylipins including 12,13-diHOME (via cytochrome P450 enzymes), 9-HODE, and 13-HODE. Arachidonic acid (AA) produces additional pronociceptive mediators (PGE2, LTB4).
-
PLA2G7 Activation: Lipoprotein-associated phospholipase A2 (Lp-PLA2) cleaves oxidized phospholipids, generating lysophospholipids (LPC, LPE) that accumulate in DRG tissue.
-
DRG Receptor Activation:
- TRPV1 channels (capsaicin receptors) on DRG neurons are directly activated by 9-HODE and 13-HODE at concentrations as low as 1-10 μM.
- Lysophospholipids activate G-protein coupled receptors (GPR55, GPR119) and modulate TRP channels.
- 12,13-diHOME activates TRPV1 and TRPA1, lowering activation thresholds.
-
Neuronal Sensitization:
- Ca²⁺ influx through activated TRPV1 → PKC and PKA activation → phosphorylation of voltage-gated sodium channels (Nav1.7, Nav1.8, Nav1.9) → increased neuronal excitability.
- NF-κB activation → upregulation of pro-inflammatory cytokine receptors (IL-1R, TNF-R1) and pain-related neuropeptides (substance P, CGRP).
- ERK1-2 phosphorylation → increased expression of TRPV1 and Nav channels (transcriptional sensitization).
-
Satellite Glial Cell Activation: Satellite cells surrounding DRG neurons detect ATP released from sensitized neurons → P2X7 receptor activation → release of IL-1β, IL-6, TNF-α → paracrine sensitization of neighboring neurons → spatial spread of hyperexcitability.
-
Axonal Degeneration: Chronic oxylipin exposure → mitochondrial dysfunction in DRG neurons → reduced ATP → impaired axonal transport → dying-back neuropathy → reduced intraepidermal nerve fibre density (IENFD <5 fibers/mm in distal leg indicates small fiber neuropathy).
graph TD
A[High Dietary LA/AA] --> B[12-LOX/15-LOX/COX-2]
B --> C["Oxylipins: 9-HODE, 13-HODE, 12,13-diHOME"]
A --> D[PLA2G7]
D --> E["Lysophospholipids: LPC, LPE"]
C --> F[TRPV1/TRPA1 Activation]
E --> F
F --> G["Ca²⁺ Influx"]
G --> H[PKC/PKA Activation]
H --> I[Nav1.7/1.8/1.9 Phosphorylation]
I --> J[Increased Excitability]
G --> K["NF-κB Activation"]
K --> L[Substance P/CGRP Expression]
J --> M[Peripheral Sensitization]
L --> M
M --> N[Central Sensitization]
G --> O[ATP Release]
O --> P[Satellite Glia P2X7]
P --> Q["IL-1β/IL-6/TNF-α"]
Q --> M
G --> R[Mitochondrial Dysfunction]
R --> S[Axonal Degeneration]
S --> T[Reduced IENFD]
Protective Mechanisms:
Early Life Programming:
Early life stress (maternal separation) alters DRG ion channel expression patterns in a sex-dependent manner, increasing Nav1.8 (pain-specific sodium channel) and reducing Kv1.2 (stabilizing potassium channel), creating a vulnerability to later-life pain sensitization. This is mediated by epigenetic modifications (DNA methylation) at the Nav1.8 promoter.
The DRG represents the first amplification point in chronic pain pathology—where metabolic dysfunction translates into neuropathic signaling. This is where the selfish immune system meets the selfish brain: inflammatory metabolites designed for host defense (oxylipins were evolutionarily adaptive as antimicrobial lipids) now drive maladaptive pain sensitization in the context of evolutionary mismatch.
Exam-Relevant Clinical Application:
-
Unexplained Neuropathy Patients: In patients presenting with burning foot pain, tingling, or allodynia WITHOUT diabetes or B12 deficiency, consider DRG sensitization from high omega-6 intake. Standard neuropathy workup (EMG, blood glucose, HbA1c, B12, TSH) may be normal. Request skin biopsy for IENFD (gold standard for small fiber neuropathy) and assess dietary omega-6 to omega-3 ratio.
-
Diet as First-Line Intervention: Reducing dietary linoleic acid (<5% total calories, down from typical Western 7-10%) by eliminating seed oils (sunflower, safflower, corn, soybean) and increasing omega-3 fatty acids (2-4g EPA+DHA daily) has been shown to reduce plasma oxylipins by 40-60% within 12 weeks. This is more effective than pregabalin for metabolic neuropathy in some studies.
-
Fibromyalgia and Chronic Fatigue Syndrome: Many patients with widespread pain have undiagnosed small fiber neuropathy (40-60% in some cohorts). DRG sensitization explains the paradox of "pain without tissue damage"—the damage is at the DRG level, invisible to standard imaging.
-
Post-Viral Neuropathy (Long COVID, Epstein-Barr Virus): Viral infections can directly infect DRG neurons (like varicella-zoster virus in postherpetic neuralgia) or trigger inflammatory metabolite accumulation. The COVID-19 virus binds ACE2 receptors expressed on DRG neurons, potentially explaining persistent neuropathic pain in Long COVID.
-
Central sensitization Prevention: Treating DRG pathology early (within 3-6 months of symptom onset) prevents the transition to central sensitization, where spinal cord and brain plasticity make pain chronic and treatment-resistant. Once microglia in the dorsal horn are activated, resolution becomes exponentially harder.
-
Metamodel Integration:
- Metamodel 1 (Movement): Reduced physical activity due to pain → loss of exercise-induced BDNF and anti-inflammatory myokines → worsening DRG inflammation.
- 5 plus 2 metamodel (Oxygen): DRG neurons are highly metabolic; intermittent hypoxia from sleep apnea or sedentary behavior → HIF-1 activation → increased TRPV1 expression.
- Energy Distribution: DRG neurons compete for glucose with activated immune cells; chronic inflammation → metabolic competition → neuronal energy deficit → axonal degeneration.
Clinical Threshold:
- IENFD <7.63 fibers/mm (distal leg) = diagnostic for small fiber neuropathy
- Omega-6:Omega-3 ratio >10:1 = high risk for DRG sensitization (optimal <4:1)
- Plasma 12,13-diHOME >100 ng/mL correlates with pain intensity in metabolic neuropathy
- DRG contain the cell bodies of all primary sensory neurons—damage here affects pain, temperature, touch, and proprioception simultaneously
- Pseudo-unipolar neurons: one axon splits into peripheral and central branches, making the DRG cell body a metabolic bottleneck vulnerable to nutrient/toxin accumulation
- Located outside the blood-brain barrier, making DRG more exposed to systemic inflammatory mediators than CNS neurons
- High linoleic acid diets (>7% calories) increase DRG oxylipin levels by 300-500% compared to low-LA diets
- TRPV1 channel activation threshold drops from 43°C to 35°C (body temperature) in the presence of pronociceptive oxylipins—creating spontaneous pain
- PLA2G7 is upregulated in metabolic syndrome and type 2 diabetes, accelerating lysophospholipid accumulation in DRG
- Satellite glial cells (SGCs) outnumber neurons 10:1 in DRG; their activation creates a self-amplifying inflammatory loop
- Early life stress increases Nav1.8 expression in DRG by 40-60%, persisting into adulthood (epigenetic scar)
- NGF (nerve growth factor) released from inflamed tissues binds TrkA Receptor on DRG neurons → retrograde transport to cell body → transcriptional upregulation of pain channels (feed-forward loop)
- DRG neurons express both CB1 and CB2 receptors—endocannabinoid system activation (via exercise, omega-3s) reduces TRPV1 sensitization
- Reduced IENFD correlates with pain intensity (r = -0.65), making skin biopsy both diagnostic and prognostic
- Varicella-zoster virus establishes latency in DRG neurons; reactivation causes shingles and postherpetic neuralgia (severe neuropathic pain in 10-20% of cases)
- linoleic acid — primary dietary precursor to pronociceptive oxylipins that accumulate in and sensitize DRG neurons
- arachidonic acid — omega-6 fatty acid metabolized to PGE2 and LTB4, activating pain receptors on DRG neurons
- PLA2G7 — lipoprotein-associated phospholipase that generates lysophospholipids accumulating in DRG tissue
- oxylipins — bioactive lipid metabolites (9-HODE, 13-HODE, 12,13-diHOME) that directly activate TRPV1 channels on DRG neurons
- TRPV1 — capsaicin receptor on DRG neurons, activated by dietary oxylipins, lowering pain threshold to body temperature
- peripheral neuropathy — caused by DRG neuron degeneration from chronic oxylipin exposure and mitochondrial dysfunction
- intraepidermal nerve fibre density — gold standard biomarker for small fiber neuropathy; reduced by DRG-mediated axonal degeneration
- darapladib — selective PLA2G7 inhibitor that prevents lysophospholipid accumulation and reduces neuropathic pain in animal models
- omega-6 to omega-3 ratio — ratios >10:1 drive excessive oxylipin production in DRG; optimal <4:1 for pain prevention
- lysophospholipids — produced by PLA2G7, activate GPR55/119 and modulate TRP channels on DRG neurons
- chronic pain syndromes — DRG sensitization is the initiating event in many chronic pain conditions (fibromyalgia, complex regional pain syndrome)
- inflammation — systemic inflammatory cytokines (IL-1β, TNF-α) cross-sensitize DRG neurons via satellite glial cell activation
- early life stress — maternal separation alters DRG ion channel expression (increased Nav1.8, decreased Kv1.2) via DNA methylation
- NGF — nerve growth factor binds TrkA receptors on DRG neurons, causing retrograde transcriptional upregulation of pain mediators
- central sensitization — DRG peripheral sensitization is a necessary precursor; treating DRG pathology prevents central transition
- omega-3 fatty acids — EPA/DHA competitively inhibit oxylipin production and generate resolvins that suppress DRG TRPV1 activity
- diet-induced neuropathy — high LA/low omega-3 diets cause DRG oxylipin accumulation, explaining metabolic neuropathy without diabetes
- neuropathic pain — characterized by burning, tingling, allodynia; initiated by DRG neuron hyperexcitability and ectopic discharge
- peripheral sensitization — lowered activation threshold and increased responsiveness of DRG nociceptors to stimuli
- dorsal horn — second-order neurons receiving input from DRG; DRG hyperactivity drives dorsal horn microglial activation
- sensory cortex — receives processed sensory information from DRG via spinothalamic tract; altered firing patterns create pain perception
- pain matrix — brain network (insula, ACC, somatosensory cortex) activated by signals originating in sensitized DRG neurons
- satellite glial cells — support cells in DRG that become activated by neuronal ATP release, releasing inflammatory cytokines
- BDNF — brain-derived neurotrophic factor released by exercise; reduces DRG TRPV1 expression and enhances GABAergic inhibition
- capsaicin — TRPV1 agonist that causes initial pain then desensitization; mechanism exploited in topical pain treatments
- TRP channels — family of ion channels (TRPV1, TRPA1, TRPM8) on DRG neurons that detect temperature, chemicals, and mechanical stimuli
- varicella-zoster virus — establishes latency in DRG neurons; reactivation causes shingles and postherpetic neuralgia
- postherpetic neuralgia — severe chronic neuropathic pain following shingles, caused by VZV damage to DRG neurons
- COVID-19 — SARS-CoV-2 binds ACE2 receptors on DRG neurons, potentially causing direct infection and long-term neuropathic pain
- fibromyalgia — 40-60% have small fiber neuropathy on skin biopsy; DRG sensitization may explain widespread pain without tissue damage
- metabolic syndrome — associated with elevated PLA2G7 activity and increased DRG oxylipin accumulation
- mitochondrial dysfunction — chronic oxylipin exposure impairs DRG mitochondrial respiration, causing energy deficit and axonal degeneration
- substance P — neuropeptide released from DRG central terminals in dorsal horn; upregulated by NF-κB activation during DRG sensitization
- CGRP — calcitonin gene-related peptide released from DRG neurons; mediates neurogenic inflammation and contributes to migraine pathophysiology
- Module 1 — Diet-induced inflammation and pain mechanisms
- Module 5 — Chronic pain and neuropathic pathways